Daily Archive: November 22, 2011

Nov 22

Meet CSI International Faculty

nanda_navin2

Dr Navin C. Nanda   Profile 1.    Distinguished Professor of Medicine and Cardiovascular Disease and Director, Heart Station/Echocardiography Laboratories, University of Alabama at Birmingham, Birmingham, Alabama and Director, Echocardiography Laboratory, The Kirklin Clinic, University of Alabama Health Services Foundation, Birmingham, Alabama. 2.    Founder and President, International Society of Cardiovascular Ultrasound (since 1991) and Founder, World …

Continue reading »

Nov 22

Stress Echocardiography in Valvular Stenotic Heart Disease

S.K. Parashar, Consultant cardiologist & Director, Non invasive cardiac laboratory, Metro Hospitals & Heart Institute Stress echocardiography is emerging as an important tool in evaluation of valvular stenosis It aids in clinical decision making It provides significant non invasive information on dynamic changes in valve function, left ventricular function, hemodynamic response to exercise Exercise gives …

Continue reading »

Nov 22

Ivbradine safe in acute heart failure for reducing heart rate

Sinus tachycardia is an important predictor of mortality in patients with severe LV dysfunction of any etiology. This problem is further confounded by low blood pressure and concomitant use of inotropic drugs. In many such patients it is not possible to give beta blockers safely. Rate control can be easily achieved by use of Ivabradine …

Continue reading »

Nov 22

CABG or PCI both effective in TVD and LMCA Lesion

In patients who meet criteria for revascularization, the choice is between CABG or PCI. A prospective quality of life sub study of the SYNTAX trial of patients with TVD or LMCA disease compared the relief of angina after the interventions. At 12 months, both interventions were associated with substantial relief of angina, although there was …

Continue reading »

Nov 22

In STEMI Radial PCI better than femoral PCI

The RIVAL trial randomly assigned 7021 patients to either femoral or radial artery access for coronary angiography and intervention. At 30 days, there was no significant difference in the rate of the primary composite outcome (death, myocardial infarction, stroke, or noncoronary artery bypass graft related major bleeding). Radial artery catheterization was however better in patients …

Continue reading »

Nov 22

Apixaban or rivaroxaban in atrial fibrillation

One should use a direct thrombin inhibitor or a factor Xa inhibitor rather than warfarin in patients with AF requiring anticoagulation. Apixaban and rivaroxaban do not require lab monitoring. [ARISTOTLE (apixaban), ROCKET-AF (rivaroxaban), RE-LY trial (dabigatran: N Engl J Med 2011; 365:981; N Engl J Med 2011; 365:883; Circulation 2011; 124:1573).]

Nov 22

Antidote for newer anti coagulants

Prothrombin complex concentrate (PCC) can reverse the anticoagulant effect of rivaroxaban [Circulation 2011; 124:1573].

Nov 22

Facts and figures in cardiology

Analysis of data in over 5000 patients from the Euro Heart Survey on Valvular heart disease has shown that a 33% of elderly patients with severe, symptomatic aortic stenosis are denied valve surgery.